<DOC>
	<DOCNO>NCT01485146</DOCNO>
	<brief_summary>This Phase 1 , double-blind ( sponsor open ) , placebo control study ass safety , tolerability , pharmacokinetics pharmacodynamics multiple dos ETC-1002 healthy subject .</brief_summary>
	<brief_title>A Multiple Ascending Dose Study ETC-1002 Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Major Healthy male female subject nonchild bear potential determined medical history , physical exam vial sign measurement Body Mass Index 1832 kg/m2 inclusive body weight &gt; 50 kg Major Alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) &gt; 1.2 x Upper Limit Normal ( ULN ) , serum creatinine &gt; ULN , Hemoglobin &lt; 12.0 g/dL Clinically significant disease require physician 's care and/or would interfere study evaluation History drug alcohol abuse , consumption alcohol within 48 hour prior randomization , positive test alcohol drug high potential abuse prior randomization Use prescription nonprescription drug , vitamin , dietary supplement within 14 day prior randomization Other exclusion criterion apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>